Myrtle (Myrtus communis)

Nomenclature & Taxonomic Classification

• Botanical Binomial: Myrtus communis L.
• Family: Myrtaceae
• Common Name(s): Myrtle, Common Myrtle, True Myrtle
• Parts Used: Dried leaves and essential oil.

Botanical Description, Habitat & Sustainability

• Physical Description: * Growth Habit: A dense, aromatic, evergreen shrub growing 1 to 3 meters in height.
  • Morphology: Leaves are opposite, ovate-lanceolate, acute, dark shiny green, glabrous, and contain visible translucent oil glands that emit a pleasant aromatic scent when crushed. Flowers are star-like, white, with numerous protruding stamens. The fruit is a globose, blue-black berry.
• Habitat & Cultivation: Native to the Mediterranean region, Southern Europe, and Western Asia. Thrives in dry, sunny areas, scrublands (maquis), and woods.
• Sustainability Status: Secure under cultivation and widely naturalized.

Energetics & Traditional Actions

• Western Tissue States: Corrects Relaxation (atony/excessive discharges) and Torpor (bacterial overgrowth).
• Traditional Vector:
  • Ayurveda: Rasa (Taste): Kashaya (Astringent), Tikta (Bitter) | Virya (Energy): Sheeta (Cooling) | Vipaka (Post-Digestive Effect): Katu (Pungent) | Dosha Modulation: Reduces Pitta and Kapha; elevates Vata in excess.
  • Traditional Chinese Medicine: Temperature: Cool | Taste: Astringent, Bitter | Organ Meridians Entered: Lung, Large Intestine, Bladder
• Historical Folk Use: Associated with Aphrodite in ancient Greece as a symbol of love. Historically deployed in Mediterranean medicine as an astringent wash for leucorrhea, an antiseptic treatment for pulmonary catarrh, and a remedy for chronic diarrhea and dysentery.

Phytochemistry & Pharmacological Dynamics

• Primary Phytochemicals: Volatile oil (0.5–1%, containing cineole [eucalyptol], alpha-pinene, myrtenol, limone), tannins (hydrolyzable and condensed), acylphloroglucinols (myrtucommulones A and B), and flavonoids (myricetin, quercetin).
• Mechanism of Action: > Myrtucommulones function as powerful antimicrobial and anti-inflammatory agents by selectively suppressing 5-lipoxygenase and inhibiting cyclooxygenase pathways. The volatile compound cineole acts as a secretolytic expectorant within the pulmonary tract, stimulating bronchial ciliary movement and decreasing mucus viscosity. Simultaneously, its high tannin profile accounts for an immediate localized astringent action, effectively tightening leaky cell membranes and curbing excessive mucosal discharges.

Clinical Applications & Indications

• Primary Indications: Sinusitis, chronic bronchitis, dry or productive respiratory tract catarrh, and topically for varicose ulcers, hemorrhoids, and vaginal leucorrhea.
• Secondary Indications: Mild diarrhea, aphthous ulcers (as a mouthwash), and oily skin or acne management.
• Modern Clinical Evidence: Randomized, double-blind trials validate Myrtle leaf standardized extracts and essential oils in significantly reducing the symptom duration and recurrence rates of chronic rhinosinusitis and acute bronchitis due to its reliable mucolytic and antibacterial performance.

Preparation, Dosing & Extraction Matrix

• Optimal Menstruum & Extraction Guidelines: Mid-to-high hydroethanolic solvents (50–65% EtOH) are necessary to capture the volatile oils and myrtucommulones. Infusions work well for localized external astringent douches or mouthwashes.

Standard Dosage Parameters

Safety Profile, Contraindications & Drug Interactions

• Contraindications: Avoid internal therapeutic quantities during pregnancy and lactation due to limited safety data. Do not apply essential oils directly onto the faces of infants or young children due to risks of reflexive laryngeal spasm.
• Side Effects & Toxicity Thresholds: Ingestion of whole plant leaves is safe. Isolated essential oil overdosage can trigger nausea, vomiting, and central nervous system depression.
• Pharmaceutical Cross-Interactions: * Enzyme Alterations: High internal cineole loads can induce liver enzymes like CYP2B6 minorly over prolonged use.
  • Additive Pathways: Mucolytics: Acts synergistically with pharmaceutical mucolytics (e.g., acetylcysteine).

References

1. Feerst, M. (1998). The Aromatherapy Handbook.
2. Fedotova, J., et al. (2016). Phytochemical and pharmacological profiles of Myrtus communis L. Journal of Ethnopharmacology, 182, 1-13.
3. European Medicines Agency (EMA). (2015). Assessment report on Myrtus communis L., folium. EMA/HMPC/164084/2014.